Rapid Communication
Copyright ©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jan 21, 2006; 12(3): 473-478
Published online Jan 21, 2006. doi: 10.3748/wjg.v12.i3.473
Figure 5
Figure 5 Bone marrow-derived DC pulsed with HSCT-26 lysate can generate tumor-specific CTLs in vivo. Splenic T cells obtained from immunized mice were evaluated for cytolytic activity against Mitomycin C treated CT-26 cells at the effector: target (E:T) ratios indicated. Values are the mean ± SE of triplicate wells.